Atria Investments’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.15M Buy
377,655
+39,371
+12% +$953K 0.09% 228
2026
Q1
$8.2M Buy
338,284
+11,714
+4% +$284K 0.09% 237
2025
Q4
$7.91M Buy
326,570
+114,758
+54% +$2.78M 0.09% 247
2025
Q3
$5.15M Buy
211,812
+4,562
+2% +$110K 0.06% 381
2025
Q2
$5.03M Sell
207,250
-24,201
-10% -$585K 0.06% 382
2025
Q1
$5.6M Buy
231,451
+9,681
+4% +$234K 0.07% 335
2024
Q4
$5.34M Buy
221,770
+92,054
+71% +$2.22M 0.07% 328
2024
Q3
$3.15M Sell
129,716
-8,215
-6% -$198K 0.04% 508
2024
Q2
$3.29M Sell
137,931
-5,643
-4% -$134K 0.04% 466
2024
Q1
$3.42M Buy
143,574
+16,511
+13% +$394K 0.05% 451
2023
Q4
$3.04M Buy
+127,063
New +$2.98M 0.05% 445
2023
Q3
– Hold
0
– – – 698

Other funds holding IBDR

Atria Investments's IBDR Position: Q2 2026 in Review

Atria Investments increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 12% in Q2 2026, buying an estimated $953K and bringing the position to 377,655 shares worth $9.15M. The position accounts for 0.09% of the portfolio, ranked #228.

Atria Investments first reported a position in IBDR in Q4 2023 and has held it in 11 quarters since. 424 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

  • Atria Investments held 377,655 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $9.15M as of Q2 2026.
  • Atria Investments bought 39,371 iShares iBonds Dec 2026 Term Corporate ETF shares in Q2 2026, an estimated $953K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.09% of Atria Investments's portfolio in Q2 2026, its #228 holding.
  • Atria Investments first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 424 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.